---
title: "Federal Health Policy Set for Overhaul After Democrats' Election Rout"
url: https://newscentral.site/federal-health-policy-set-for-overhaul-after-democrats-election-rout/
language: en
publisher: "News Central Site"
section: "Politics"
published: 2026-11-04T21:53:00.000Z
updated: 2026-11-08T07:45:34.894Z
id: 4002cb1f-f334-485a-bc69-5232616c8889
source: "CBS News Politics https://www.cbsnews.com/news/democrats-2026-midterm-election-health-policy/"
attribution: "Link to https://newscentral.site/federal-health-policy-set-for-overhaul-after-democrats-election-rout/ and name News Central Site when you quote or summarize this story."
---

# Federal Health Policy Set for Overhaul After Democrats' Election Rout

The Democratic Party is likely to push for significant changes in healthcare legislation following their election victory.

Democrats' election rout is poised to reorder federal health policy, with ambitious proposals on the table to expand Medicare coverage to all Americans.

Progressive candidates, such as Michigan's Dr Abdul El-Sayed, are likely to embolden their party to push for significant changes in healthcare legislation. This could include expanding Medicare, a program currently reserved for people over 65, to cover the entire population.

The Democratic Party is on track to secure at least 237 seats in the House and 54 Senate seats, as per early election projections by The Associated Press.

The Republican Party had touted their overhaul of Medicaid as a key achievement in their midterm campaigns, along with other changes to health programs enacted through their One Big Beautiful Bill Act.

However, Democrats are now poised to take control of federal health policy and will need to carefully balance their legislative priorities with investigations into concerns surrounding the nation's top health official. This delicate balancing act will be crucial as Democrats prepare to tackle a range of pressing issues in 2027.

A key priority for Democrats is likely to be restoring enhanced subsidies that reduced the cost of Obamacare health plans for millions of people, which expired at the end of last year. Advocates say extending these subsidies and lengthening the enrollment period could help more individuals access affordable healthcare, with some predicting decisive action on this front could lead to significant benefits in 2027.

The White House is likely to continue playing a significant role in shaping health policy despite the Democrats' election victory, as President Trump is expected to rely heavily on executive actions to achieve his goals.

President Trump's administration has already made clandestine deals with pharmaceutical companies, providing relief from certain tariffs in exchange for concessions. However, details of these agreements remain secret, with no contracts or paperwork having been made public, fueling Democratic concerns about transparency and accountability.

Democrats are poised to gain subpoena power through their control of congressional committees, a crucial tool for investigation. This will enable them to scrutinize the Trump administration's dealings with pharmaceutical companies, including the clandestine deals that have raised eyebrows in Washington.

The Trump administration's handling of pharmaceutical companies will be under increased scrutiny as Democrats prepare to take control of key committees and agencies.

A crucial step in this process is the confirmation vote for Heidi Overton to lead the Food and Drug Administration, which has been without a top leader since May. This appointment has sparked debate among lawmakers, with some Republicans expressing concerns that she may not be strict enough on medication abortion access.

Meanwhile, Congress is also poised to tackle bipartisan issues, such as preventing cuts to Medicare payments to doctors scheduled for January 1, and making amendments to the No Surprises Act, a federal law designed to protect consumers from surprise medical bills.

As the dust settles on the recent elections, Washington lawmakers face a pressing challenge: addressing healthcare affordability concerns that have been consistently top-of-mind for voters. With voters having ranked healthcare as one of their most important issues in recent polls, any failure to tackle these concerns could result in widespread voter discontent.

Reining in high prescription drug prices may be an area where bipartisan cooperation can yield results, given past statements from prominent figures like former President Trump, who touted lowering some drug prices as a notable achievement. According to Matt Hogan, a partner at Impact Research, the issue of affordability has been a dominant theme in three consecutive elections.

Efforts to address this pressing concern will require lawmakers to put aside partisan differences and work together towards common goals, making healthcare more affordable for millions of Americans.

---
Source: [CBS News Politics](https://www.cbsnews.com/news/democrats-2026-midterm-election-health-policy/)  
Published by News Central Site: https://newscentral.site/federal-health-policy-set-for-overhaul-after-democrats-election-rout/
